Atlas Trials

Optimal EGFR TKIs Treatment Strategies for Lung Adenocarcinoma Harboring EGFR Exon 19 Deletion Variants

Clinical trial NCT04370860 · COMPLETED

Trial details

NCT number
NCT04370860
Sponsor
National Taiwan University Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
EGFR Exon 19 MutationTumor Progression
Start date
2020-05-01
Primary completion
2021-12-31
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.